New drugs for the treatment of schizophrenic patients.

New drugs for the treatment of schizophrenic patients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

New drugs for the treatment of schizophrenic patients. Abstract Text:

W W Fleischhacker,

Conventional neuroleptics are widely accepted as being effective against the positive symptoms of schizophrenia, but do not benefit all patients. Furthermore, they are relatively ineffective against negative symptoms and cognitive disorders, and most have unpleasant side effect profiles. New strategies for treating schizophrenia include the development of dopamine antagonists with high selectivity for different subtypes of dopamine receptors, dopamine partial agonists, antagonists at different serotonin (5-hydroxytryptamine; 5-HT) receptor subtypes, drugs with mixed pharmacological profiles and drugs which modify transmission via amino acids or peptides in the brain. The prospect is that some of these strategies will lead to the introduction of new drugs and that some of these will become the standards against which future drugs will be compared. The search for new drugs and their use in clinical practice will also lead to developments in our knowledge and understanding of schizophrenia.

New drugs for the treatment of schizophrenic patients. Publishing Authors By Initials

WW Fleischhacker,

For similar behavioral disciplines and activities: schizophrenic psychology research abstracts see: behavioral disciplines and activities: schizophrenic psychology research

PUBMED ID PMID:

MEDLINE DATE:

New drugs for the treatment of schizophrenic patients. Journal Published:

PUBLICATION TYPE: Review

Journal: Acta psychiatrica Scandinavica. Supplementum

VOLUME: 388

Page Numbers: 24-30

Journal Abbreviation:

ISSN: 0065-1591

DAY: 15

MONTH: 02

YEAR: 1995

New drugs for the treatment of schizophrenic patients. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370365

New drugs for the treatment of schizophrenic patients. Keywords Mesh Terms:

KEYWORDS: Schizophrenic Psychology

MESH TERMS: drug therapy

Chemical & Substance for Abstract: New drugs for the treatment of schizophrenic patients. Information

Substance Name: Receptors, Neurotransmitter

Registry Number: 0

Grant and Affiliation Information for New drugs for the treatment of schizophrenic patients.

AFFILIATION: Department of Biological Psychiatry, University of Innsbruck Medical School, Austria.

Country: DENMARK

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Psychiatr Scand Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

New drugs for the treatment of schizophrenic patients Related Publications

• Alcohol and/or benzodiazepine use in injured road users.
• Alcohol and/or benzodiazepine use: different accidents--different impacts?
• An improved method for the isolation of free-circulating plasma DNA and cell-free DNA from other body fluids.
• Brain activation patterns during a selective attention test-a functional MRI study in healthy volunteers and patients with schizophrenia.
• Clock drawing, clock reading, clock setting, and judgment of clock faces in elderly people with dementia and depression.
• Compliance with antipsychotic treatment.
• Conflicting views on conflicts of interest in medicine.
• Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease.
• Interpretation of the Pandy test.
• Language lateralization in unmedicated patients during an acute episode of schizophrenia: a functional MRI study.
• Longitudinal volumetric MRI study in first- and multiple-episode male schizophrenia patients.
• Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunity.
• New drugs for the treatment of schizophrenic patients.
• No evidence for an association between serum cholesterol and the course of depression and suicidality.
• Not Available
• Not Available
• Perspectives on treatment needs in schizophrenia.
• Schizophrenia today: do we know any more and can we treat it better than a decade ago?
• Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
• [Beta blockers in psychiatric diseases. Indications and problems]
• [Blood diseases.]
• [Blood diseases.]
• [Blood diseases.]
• [Cytostatic therapy.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Preleukemic states.]
• [The problems of older people]